CBD: Clinical Trials

9 trials for CBD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 unknown, 1 active not recruiting, 1 withdrawn. 9 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Completed 4, Unknown 3, Active not recruiting 1, Withdrawn 1
Phase 33Unknown 2, Completed 1
Phase 12Completed 1, Unknown 1

Follow CBD: new trials by email Literature Review of CBD trials Research Report on CBD

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders)
5% polymer gel with CBD application, 10% polymer gel with CBD application, Placebo intervention - Temporomandibular Disorder, Myofascial Pain
Phase 2 / Phase 3UnknownMedical University of Silesia302023-07-182023-07-21
The Use of Cannabinoid Patch for Knee Osteoarthritis
Topical CBD Patch, Placebo Patch - Knee Osteoarthritis, CBD
Phase 2WithdrawnNorthwell Health2022-10-012023-01-19
RCT of CBD for Anxiety in Advanced Breast Cancer
Cannabidiol, Placebo - Advanced Breast Cancer, Anxiety
Phase 2Active not recruitingDana-Farber Cancer Institute602022-01-192026-08-19
Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task
CBD, Placebo - CBD
Phase 1 / Phase 2UnknownHartford Hospital202021-12-152024-04-12
A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain
Cybis™ 10:25 THC:CBD oil - Chronic Pain, Neck Pain
Phase 1 / Phase 2CompletedCymra Life Sciences282021-09-202022-07-07
Methodology for Developing an Occlusal Appliance With CBD Active Carrier
CBD occlusal appliance, Acrylic resin occlusal appliance - Temporomandibular Disorder, Myofascial Pain
Phase 2 / Phase 3UnknownMedical University of Silesia402021-01-012021-03-01
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
THC ~5%, CBD ~12%, THC ~5% and CBD ~12% - Migraine, Cannabis
Phase 2CompletedUniversity of California, San Diego922020-11-202023-02-28
Is Topical CBD Effective in Treating Thumb Joint Arthritis
CBD, Shea Butter - CBD, Hand Osteoarthritis
Phase 2CompletedUniversity of Virginia182020-07-282025-07-03
Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm
Cannabidiol Oral Solution [Epidiolex] - Blepharospasm, Blepharospasm, Benign Essential
Phase 2 / Phase 3CompletedSilkiss Eye Surgery122020-05-202021-11-02

Narrower conditions

Marijuana Abuse (2)  ·  Temporomandibular Joint Disorders (2)  ·  Anxiety Disorders (1)  ·  Back Pain (1)  ·  Benign essential blepharospasm (1)  ·  Blepharospasm (1)  ·  Bruxism (1)  ·  Chronic Pain (1)  ·  Facial Pain (1)  ·  Migraine Disorders (1)  ·  Neck Pain (1)  ·  Osteoarthritis (1)  ·  Osteoarthritis, Knee (1)  ·  Pain (1)

Broader conditions

Joint Diseases (3)  ·  Mental Disorders (3)  ·  Musculoskeletal Diseases (3)  ·  Chemically-Induced Disorders (2)  ·  Craniomandibular Disorders (2)  ·  Jaw Diseases (2)  ·  Mandibular Diseases (2)  ·  Muscular Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Stomatognathic Diseases (2)  ·  Substance-Related Disorders (2)  ·  Arthritis (1)  ·  Behavior (1)

Interventions

Cannabidiol (3)  ·  Dronabinol (1)  ·  THC 5 (1)  ·  nabiximols (1)  ·  salicylhydroxamic acid (1)

Sponsors

Medical University of Silesia (2)  ·  Cymra Life Sciences (1)  ·  Dana-Farber Cancer Institute (1)  ·  Hartford Hospital (1)  ·  Northwell Health (1)  ·  Silkiss Eye Surgery (1)  ·  University of California, San Diego (1)  ·  University of Virginia (1)

Countries

United States (6)  ·  Poland (2)  ·  Australia (1)

Top investigators

Godfrey Pearlson, MD (1)  ·  Ilana Braun, MD (1)  ·  Magdalena Antonowicz, Adiunct (1)  ·  Nathaniel M Schuster, MD (1)  ·  Richard Chye (1)  ·  Robert Duarte, MD (1)  ·  Vijay Rasquinha, MD (1)

Results publications

PMID 37606606, PMID 39680411, PMID 41469488, PMID 41517391